A modeling‐based proposal for safe and efficacious reintroduction of bedaquiline after dose interruption: A population pharmacokinetics study by Lina Keutzer, Yasamin Akhondipour Salehabad, Lina Davies Forsman, Ulrika S. H. Simonsson

Connect to this object online.

New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon? by Ricky Hao Chen, Andrew Burke, Jin-Gun Cho, Jan-Willem Alffenaar, Lina Davies Forsman

Connect to this object online.

Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis by Haoyue Zhang, Yuying He, Lina Davies Forsman, Lina Davies Forsman, Jakob Paues, Jakob Paues, Jim Werngren, Katarina Niward, Katarina Niward, Thomas Schön, Thomas Schön, Thomas Schön, Judith Bruchfeld, Judith Bruchfeld, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Yi Hu

Connect to this object online.

Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients by Ge Shao, Ziwei Bao, Lina Davies Forsman, Lina Davies Forsman, Jakob Paues, Jakob Paues, Jim Werngren, Katarina Niward, Katarina Niward, Thomas Schön, Thomas Schön, Thomas Schön, Judith Bruchfeld, Judith Bruchfeld, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Yi Hu

Connect to this object online.

Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis by Shulan Dong, Ge Shao, Lina Davies Forsman, Sainan Wang, Shanshan Wang, Jiayi Cao, Ziwei Bao, Judith Bruchfeld, Jan-Willem C. Alffenaar, Jia Liu, Yi Hu, Meiying Wu

Connect to this object online.